FI963674A0 - Recombinant DNA adenovirus encoding brain-derived neurotrophic factor (BDNF) - Google Patents
Recombinant DNA adenovirus encoding brain-derived neurotrophic factor (BDNF)Info
- Publication number
- FI963674A0 FI963674A0 FI963674A FI963674A FI963674A0 FI 963674 A0 FI963674 A0 FI 963674A0 FI 963674 A FI963674 A FI 963674A FI 963674 A FI963674 A FI 963674A FI 963674 A0 FI963674 A0 FI 963674A0
- Authority
- FI
- Finland
- Prior art keywords
- bdnf
- recombinant dna
- neurotrophic factor
- derived neurotrophic
- adenovirus encoding
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Virology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9403191A FR2717496B1 (en) | 1994-03-18 | 1994-03-18 | Recombinant viruses, preparation and use in gene therapy. |
PCT/FR1995/000250 WO1995025804A1 (en) | 1994-03-18 | 1995-03-02 | Recombinant adenoviruses coding for brain-derived neurotrophic factor (bdnf) |
Publications (2)
Publication Number | Publication Date |
---|---|
FI963674A FI963674A (en) | 1996-09-17 |
FI963674A0 true FI963674A0 (en) | 1996-09-17 |
Family
ID=9461190
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI963674A FI963674A0 (en) | 1994-03-18 | 1996-09-17 | Recombinant DNA adenovirus encoding brain-derived neurotrophic factor (BDNF) |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP0750676A1 (en) |
JP (1) | JPH09510358A (en) |
KR (1) | KR970701784A (en) |
AU (1) | AU703793B2 (en) |
CA (1) | CA2184200A1 (en) |
FI (1) | FI963674A0 (en) |
FR (1) | FR2717496B1 (en) |
IL (1) | IL112992A0 (en) |
MX (1) | MX9603490A (en) |
NO (1) | NO963559L (en) |
WO (1) | WO1995025804A1 (en) |
ZA (1) | ZA952244B (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5830857A (en) * | 1995-07-14 | 1998-11-03 | Amgen Inc. | Method of treating epilepsy |
FR2753379B1 (en) | 1996-09-13 | 1998-10-30 | Rhone Poulenc Rorer Sa | METHOD OF TREATING AMYOTROPHIC SIDE SCLEROSIS |
CA2408255A1 (en) * | 2000-05-05 | 2001-11-15 | Marie T. Filbin | Methods for stimulating nervous system regeneration and repair by regulating arginase 1 and polyamine synthesis |
US20210079050A1 (en) * | 2018-02-20 | 2021-03-18 | Carmel Haifa University Economic Corporation Ltd. | Compositions and methods for delivery and expression of small inhibitory peptides and use thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE202939T1 (en) * | 1991-07-10 | 2001-07-15 | Regeneron Pharma | METHOD FOR TREATING MOTOR NEURON DISEASES BY MEMBERS OF THE BDNF/NT-3/NGF FAMILY |
US5733871A (en) * | 1991-11-08 | 1998-03-31 | The General Hospital Corporation | Methods for the treatment of neuronal damage associated with ischemia, hypoxia or neurodegeneration |
FR2688514A1 (en) * | 1992-03-16 | 1993-09-17 | Centre Nat Rech Scient | Defective recombinant adenoviruses expressing cytokines and antitumour drugs containing them |
WO1994003199A1 (en) * | 1992-08-04 | 1994-02-17 | Regeneron Pharmaceuticals, Inc. | Method of enhancing differentiation and survival of neuronal precursor cells |
JPH08501686A (en) * | 1992-09-25 | 1996-02-27 | ローン−プーラン・ロレ・ソシエテ・アノニム | Adenovirus vector for transfer of foreign gene to cells in central nervous system, especially brain |
FR2704234B1 (en) * | 1993-04-22 | 1995-07-21 | Centre Nat Rech Scient | RECOMBINANT VIRUSES, PREPARATION AND USE IN GENE THERAPY. |
-
1994
- 1994-03-18 FR FR9403191A patent/FR2717496B1/en not_active Expired - Fee Related
-
1995
- 1995-03-02 AU AU18962/95A patent/AU703793B2/en not_active Ceased
- 1995-03-02 MX MX9603490A patent/MX9603490A/en not_active Application Discontinuation
- 1995-03-02 KR KR1019960705207A patent/KR970701784A/en not_active Application Discontinuation
- 1995-03-02 CA CA002184200A patent/CA2184200A1/en not_active Abandoned
- 1995-03-02 EP EP95911371A patent/EP0750676A1/en not_active Ceased
- 1995-03-02 WO PCT/FR1995/000250 patent/WO1995025804A1/en not_active Application Discontinuation
- 1995-03-02 JP JP7524417A patent/JPH09510358A/en active Pending
- 1995-03-14 IL IL11299295A patent/IL112992A0/en unknown
- 1995-03-17 ZA ZA952244A patent/ZA952244B/en unknown
-
1996
- 1996-08-26 NO NO963559A patent/NO963559L/en not_active Application Discontinuation
- 1996-09-17 FI FI963674A patent/FI963674A0/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
FR2717496B1 (en) | 1996-04-12 |
WO1995025804A1 (en) | 1995-09-28 |
FI963674A (en) | 1996-09-17 |
FR2717496A1 (en) | 1995-09-22 |
AU1896295A (en) | 1995-10-09 |
JPH09510358A (en) | 1997-10-21 |
EP0750676A1 (en) | 1997-01-02 |
KR970701784A (en) | 1997-04-12 |
MX9603490A (en) | 1997-03-29 |
NO963559L (en) | 1996-08-26 |
CA2184200A1 (en) | 1995-09-28 |
ZA952244B (en) | 1996-01-16 |
IL112992A0 (en) | 1995-06-29 |
AU703793B2 (en) | 1999-04-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE191146T1 (en) | STABILIZED, ALBUMIN-FREE, LOW SUGAR PREPARATION CONTAINING RECOMBINANT FACTOR VIII | |
GB2347930B (en) | IGF-1 receptor interacting proteins (IIPs), genes coding therefor and uses thereof | |
EE04684B1 (en) | Moraxella catarrhalis outer membrane protein-106pol peptide, gene sequence and its use | |
FI924091A0 (en) | AUTHORIZATION PROTOCOL SOM FOERSIKTIGHETSHJAELPMELEL. | |
DE69714347D1 (en) | Elevator system with group control | |
DE69828329D1 (en) | Manually operated corkscrew with multiple support points | |
HK1033149A1 (en) | Disulfide cross-linking glycoprotein hormone analogs, and their preparation and use. | |
DE69310280D1 (en) | Alumina, calcium oxide, yttria sealant composition | |
FI963674A0 (en) | Recombinant DNA adenovirus encoding brain-derived neurotrophic factor (BDNF) | |
AU1381299A (en) | Novel genes encoding transporter-like molecules | |
IT228551Y1 (en) | COMPOSITE PANEL, PARTICULARLY SUITABLE FOR FORMWORKS AND FLOORS. | |
ATA1972000A (en) | RECOMBINANTLY MADE INTESTINAL NPT2B POLYPEPTIDE | |
NO901434D0 (en) | NEUROTROPHIC PEPTIDES. | |
EP0958304A4 (en) | Nucleotide sequence encoding the cd33-like protein | |
DE59813562D1 (en) | Pigment preparations for the inkjet process | |
DE69738977D1 (en) | NEW FUSION PROTEIN, DAFUER ENCODING GENE, REBATE APPLICATION | |
NO20022542L (en) | DNA encoding a new Ets polypeptide | |
HUP0103361A2 (en) | Factor viii homologue nucleic acids, polypeptides, methods, uses | |
GB2311736B (en) | Ultra-violet (u.v) bubble mix | |
FI884556A (en) | RECOMBINANT PLASMID DNA PPR-IFN 1-13, SOM CODE FOER SYNTES AV MAENNISKANS FIBROBLAST-1-INTERFERON, FOERFARANDE FOER FRAMSTAELLNING DAERAV OCH E.COLI INNEHAOLLANDE DETTA. | |
ITPD970057A0 (en) | TROLLEY FOR MAINSAIL | |
EP1251171A4 (en) | Novel endoplasmic reticulum-localized protein, remedies containing the same for diseases associated with glycoprotein abnormality, dna encoding this protein and gene remedies containing the same for treating diseases associated with glycoprotein abnormality | |
SE9401043D0 (en) | Ports (Pools), purification, circ., Heating | |
IL140030A0 (en) | Polypeptides dna molecules encoding them | |
ZA972556B (en) | Control for several lift groups with destination call control. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MA | Patent expired |